article_metadata: Morgan Zenatri Michael Collins Tifanie Alberto Antonio Farina Sophie Collardeau-Frachon Mélanie Saint-Jean François Bocquet Frederic Dumont Jérôme Honnorat Bastien Joubert Judith Raimbourg
article_metadata: 10.1007/s00262-024-03901-4
article_metadata: Cancer Immunol Immunother
article_metadata: 2025 Jan 3;74(2):45.
article_metadata: anti-pd1 chronic intestinal pseudo-obstruction nsclc vedolizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39751892/
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Intestinal Pseudo-Obstruction / chemically induced
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Intestinal Pseudo-Obstruction / chemically induced Case Reports Adrenal Cortex Hormones / therapeutic use Aged B7-H1 Antigen / antagonists & inhibitors Chronic Disease Female Gastrointestinal Agents / adverse effects Gastrointestinal Agents / therapeutic use Humans Immune Checkpoint Inhibitors / adverse effects Immune Checkpoint Inhibitors / therapeutic use Male Middle Aged Programmed Cell Death 1 Receptor / antagonists & inhibitors Antibodies, Monoclonal, Humanized vedolizumab Adrenal Cortex Hormones Immune Checkpoint Inhibitors Programmed Cell Death 1 Receptor B7-H1 Antigen PDCD1 protein, human Gastrointestinal Agents CD274 protein, human
article_metadata: PMC11699004
article_metadata: 39751892
article_metadata: Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results
article_metadata: 2025